Hematology/Oncology Flashcards

0
Q

If a patient presents with mucosal or petechial hemorrhages, what is the most likely bleeding disorder?

A

“Generally, petechiae and mucosal bleeding are the result of platelet problems (e.g., mild von Willebrand disease and thrombocytopenia) while hemarthrosis and hematomas are the result of a factor deficiency. Severe von Willebrand disease may present with hemarthrosis and hematomas”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

When are most hemophiliac patients identified?

A

“Up to half of hemophiliac patients do not bleed after circumcision. Depending on the severity of factor deficiency, the diagnosis may not be made until the child is very active or even in adulthood, after surgery, etc”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define hemophilia A.

A

“Hemophilia A is an X-lined deficiency of factor VIII, which presents with hematomas, bleeding, and hemarthrosis (and not generally mucosal bleeding or petechiae”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define hemophilia B.

A

“Deficiency of factor IX, or hemophilia B, also known as “Christmas Disease,” is also X-linked but is much less common”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hemophilia most often occurs in females. T or F

A

“Hemophilia rarely occurs in females but can occur in two situations: (1) the female patient is a heterozygote who has early inactivation of the second X chromosome during embryogenesis or (2) if both parents are carriers—in which case the father would have the disease overtly”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name 2 blood tests indicated for patients with suspected bleeding disorders?

A

CBC, PT, PTT, PFA-100, platelet count. The PTT is actually the most sensitive test for hemophilia. The PFA-100 (Platelet Function Assay) tests for (appropriately enough) platelet functioning and will be abnormal in von Willebrand disease”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

For a patient presenting with a known bleeding disorder and a hemarthrosis, what activity level is recommended?

A

“For a hemarthrosis or other “minor” bleeding, you should maintain a factor level of 30–40% for 72 hours. For more serious bleeding (intracranial, for example), maintain a level of 80–100% for 10 days”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

For a patient with a mild exacerbation of their bleeding disorder, name 2 treatments.

A

FFP, cryoprecipitate, factor, “Patients with mild hemophilia (and some types of von Willebrand disease) will respond to desmopressin with a transient increase in serum von Willebrand factor (vWF) and factor VIII”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is ITP?

A

isolated low platelet count (thrombocytopenia) with normal bone marrow and the absence of other causes of thrombocytopenia. It causes a characteristic purpuric rash and an increased tendency to bleed. Two distinct clinical syndromes manifest as an acute condition in children and a chronic condition in adults. The acute form often follows an infection and has a spontaneous resolution within 2 months. Chronic idiopathic thrombocytopenic purpura persists longer than 6 months without a specific cause.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What causes the acute form of ITP?

A

“Both infections and the MMR vaccine have been linked to ITP”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name two interventions that will result in a sustained increase in platelet count.

A

IVIG, Steroids, Spleenectomy. Transfused platelets will just be chomped up by Mr. Spleen. However, platelets can be used to temporize if a patient must go to the OR, etc. Most children can simply be observed. The only indication for treatment is bleeding. All of the treatments have a downside. Splenectomy is associated with a risk of sepsis. If possible, delay splenectomy until after the child is over 5 years old. Steroids may cause behavioral problems and long-term problems such as avascular necrosis. IVIG leads to a temporary increase in platelets that may last several weeks but can be associated with renal injury and anaphylaxis among other adverse effect”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the treatment for ITP in adults and children?

A

In children it is mostly supportive. “In adults, Treatment incudes (in order) steroids, Rho(D) immunoglobulin for Rh-positive patients, IVIG (which causes a transient rise in platelet numbers), and splenectomy. Other treatment options for refractory cases include rituximab or various immunosuppressive agents. The thrombopoietin-receptor agonists, romiplostim and eltrombopag, stimulate platelet production and can also be used in ITP.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is gestational thrombocytopenia?

A

“This patient likely has gestational thrombocytopenia, a condition that occurs in up to 5% of pregnant women. It is characterized by mild thrombocytopenia occurring in late gestation; the platelet count is usually >70,000/mm3 (two-thirds are between 130,000/mm3 and 150,000/mm3). The condition resolves after delivery and is not associated with severe neonatal thrombocytopenia. No specific change in routine obstetrical care is warranted, although the anesthesiologist placing an epidural may want a follow-up platelet count closer to the time of delivery”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name two causes of both a prolonged PT and PTT.

A

Severe liver disease, DIC & factor 2, 5 & 10. The three factor deficiencies that may prolong both PT and PTT are II, V, and X. Both PTT and PT may be prolonged due to severe liver disease and DIC as well. Mild vitamin K deficiency or mild liver disease generally affects the PT only. Generally, heparin affects PTT, and warfarin affects PT.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the general indications for transfusion?

A

“Hemodynamic instability due to bleeding unresponsive to 2 L of saline, Preoperative Hb of 7–8 gm/dL, Elderly patient after a myocardial infarction (MI) with a hematocrit <7 gm/dL in postoperative patients who are hemodynamically stable.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the signs of a transfusion reaction and how do you treat it?

A

“hemolytic transfusion reaction, which is generally the result of an ABO incompatibility. Patients may exhibit nausea, flushing, dyspnea, oliguria, back pain, and hypotension. Other findings include markers of hemolysis: hemoglobinuria, elevated serum-free Hb, reduced haptoglobin, and elevated bilirubin. Patients are positive for direct antiglobulin (Coombs) test. Therapy includes IV saline at a high enough rate to initiate a brisk diuresis and prevent Hb from precipitating in the kidneys causing acute tubular necrosis”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the most effective way to emergently lower the PTT in a patient taking warfarin?

A

“FFP contains all the soluble plasma proteins found in whole blood, including the vitamin K-dependent factors that are depleted by warfarin. If more sustained reversal is desired, the simultaneous administration of vitamin K is effective. The preferred route of administration of vitamin K is oral. Giving vitamin K IV is second best—it is associated with a risk of anaphylaxis and lowers INR the same degree as oral vitamin K at 24 hours. Avoid vitamin K SQ or IM, which are less effective than PO and IV routes”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is neutropenic fever and how is it treated?

A

development of fever, often with other signs of infection, in a patient with neutropenia. It is most generally recognized as a complication of chemotherapy when it is myelosuppressive (suppresses the bone marrow from producing blood cells).

Generally, patients with febrile neutropenia are treated with empirical antibiotics covering broad spectrum gram negative and positive organisms until the neutrophil count has recovered (absolute neutrophil counts greater than 500/mm3) and the fever has abated; if the neutrophil count does not improve, treatment may need to continue for two weeks or occasionally more. In cases of recurrent or persistent fever, an antifungal agent should be added.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

A patient with a history of small cell lung cancer presents with thoracolumbar pain, what should your next step be?

A

“Any patient with active malignancy complaining of back pain should be investigated for metastasis. While a plain film of the spine may be useful, the gold standard is MRI”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

The patient with the spinal cord mass, as result of a probable metastasis, what should your next step be?

A

“Patients with spinal cord compression who have aggressive interventions are more likely to retain function, including ambulation and bowel and bladder control. Surgical decompression is an option. Steroids will help reduce edema surrounding the tumor and hopefully will relieve pressure on the cord. Radiation can often provide symptomatic relief and reduce the likelihood that the tumor will spread locally to impinge on the cord. Hospice is always an option.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

A female patient who is 32 years old with a distant history of Hodkins disease treated with chemotherapy and radiation to the chest presents with complaints of shortness of breath and chest pain. Her physical exam is unremarkable and CBC is normal. What should you consider?

A

“The point here is that patients with a history of Hodgkin disease and chest radiation are at risk for a wide range of complications—even years after the disease has been successfully treated. Even though 80% of Hodgkin patients have long-term disease-free survival, one in six patients can be expected to die from late effects of therapy. Although CAD would be extremely unusual in a normal 32-year-old, a patient with a history of chest radiation has a relative risk of coronary disease of 5–10 times that of age-matched controls. thyroid disease, is highly likely, with over 50% of patients treated with chest radiation requiring thyroid hormone replacement. A TSH would be adequate screening. There is a high risk for secondary malignancy, including breast cancer, lung cancer, leukemia, sarcoma, and non-Hodgkin lymphoma (NHL). Finally, you should always be concerned about recurrence”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Name two long-term concerns for a patient who is treated successfully in her early 20s for Hodgkinson disease with chemotherapy and chest radiation.

A

“Female patients who were treated for Hodgkin disease with chemotherapy and radiation prior to age 20 have up to a 35% incidence of breast cancer by age 40. The typical latency period is 15 years. National guidelines recommend that annual mammography of Hodgkin survivors treated with chest irradiation should begin 5–8 years post-treatment, or age 40, which ever comes first. Smokers with a history of Hodgkin disease have a 20-fold increased chance of developing lung cancer when compared to nonsmokers with a history of Hodgkin disease. Also, female patients with Hodgkin disease have a 69% incidence of premature ovarian failure if treated for their cancer before age 29 and up to 96% if treated after age 30. While these statistics are improving with newer chemotherapy regimens, a patient should seek early referral to a fertility specialist if she desires pregnancy but is unable to conceive”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the characteristics of tumor lysis syndrome?

A

“tumor lysis syndrome, which can occur in a patient with a highly responsive leukemia or a bulky lymphoma being treated with chemotherapy (it rarely occurs without treatment). Tumor lysis syndrome occurs when there is rapid release of intracellular contents into the bloodstream. It is characterized by high potassium, high phosphorus, high uric acid, and low calcium. Patients may experience renal failure, arrhythmias, fatigue, muscle cramps, and tetany”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What’s the most likely cause of renal failure in a patient with tumor lysis syndrome?

A

“Patients with tumor lysis syndrome have renal failure secondary to uric acid nephropathy. This is caused by the precipitation of uric acid in the kidney, and it can be prevented by the use of allopurinol prior to the administration of chemotherapy.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

With a patient with renal failure from tumor lysis syndrome, how should you treat the renal failure?

A

“Allopurinol and oral calcium will not help this situation. The patient already has renal failure from his tumor lysis syndrome. While he may benefit from preventive measures, including aggressive hydration and allopurinol prior to undergoing chemotherapy, none of these measures are going to help his current renal failure.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the treatment for hyperkalemia?

A

“Treatment may include IV calcium gluconate, insulin and dextrose, and oral sodium polystyrene sulfonate (Kayexalate). Note that sodium bicarbonate for hyperkalemia has fallen out of favor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the two questions one needs to answer in order to determine the cause of it elevated hematocrit?

A

“1) Is it due to increased RBC mass or decreased plasma volume? (2) Is it primary erythrocytosis or secondary?”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are the potential causes of secondary elevated hematocrit level?

A

“alcoholic cirrhosis can lead to hepatocellular carcinoma which, along with other malignancies, can result in overproduction of erythropoietin, causing an elevated hematocrit. Diuretics decrease plasma volume, causing an apparent elevation of hematocrit. Testosterone injections may cause polycythemia. Finally, he has a significant smoking history that may produce a secondary polycythemia due to hypoxia and cor pulmonale.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is essential thrombocytopenia and what causes it?

A

“most common myeloproliferative disorder in the United States. ET is more common in females. Although patients are typically older when diagnosed, it is not uncommon in younger patients. Patients with ET have a higher rate of mortality than matched controls due to risk of thrombosis (arterial > venous) and bleeding events. In order to diagnose ET, other causes of thrombocytosis (e.g., inflammation, iron deficiency, recent surgery, infection, bleeding, and malignancy) must be excluded. A bone marrow biopsy may be helpful in establishing the diagnosis by demonstrating adequate iron stores and ruling out chronic myelogenous leukemia (CML) or myelodysplasia”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the most common cause of an abnormally high platelet count?

A

“The most common cause of an abnormally high platelet count is reactive thrombocytosis, which can result from iron deficiency, infection, inflammation, or malignancy. There is no increase in bleeding or clotting risk in patients with reactive thrombocytosis”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What’s the first indicator that iron replacement is working in iron deficient anemia?

A

Reticulocyte count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Ferritin is the most useful test in iron deficient anemia. T or F

A

False. “Ferritin is not a useful test for iron deficiency in hospitalized patients or in those who are chronically ill. Ferritin is an acute-phase reactant and thus may be elevated in these patients even when the patient has iron-deficiency anemia (where the ferritin should be low).”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Name two causes of failure for iron replacement therapy in iron deficient anemia.

A

“Anything that neutralizes the stomach pH will interfere with absorption including PPIs, antacids, and loss of acid producing cells (e.g., pernicious anemia). Other GI diseases (celiac disease, H. pylori) can also interfere with iron absorption. Tea and some green leafy vegetables can also reduce iron absorption.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Name two ways to increase iron absorption.

A

“Vitamin C (supplements or orange juice) enhances iron absorption and should be considered if a patient is not responding to iron therapy. Meat can also increase iron absorption (which we hate to say because one of us is a vegetarian … however, the truth hurts).”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

If oral iron is not tolerated, what other options for replacement are available?

A

“If oral iron preparations are not tolerated, IV iron preparations are available. Intramuscular preparations are best avoided due to pain at the injection site, skin discoloration, and risk for infection. Options for IV replacement include iron dextran and iron sucrose”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are the side effects of the iron replacement IVs and, more importantly, which one has less side effects associated?

A

“Iron dextran carries a risk of anaphylaxis in 0.6–2.3% of patients and other side effects in up to 25% of patients, including bronchospasm, flushing, headache, fever, urticaria, nausea, vomiting, hypotension, seizures, myalgia, arthralgia, and increased thromboembolic events. Iron sucrose has a lower incidence of side effects—typically nausea, constipation, diarrhea, or a transient minty taste—and may be given to patients who have had a previous reaction to iron dextran. “A” is incorrect because calcium will interfere with iron absorption. Not only that but also she has already said she would not take additional oral iron”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

How does anemia of chronic disease present?

A

“Anemia of chronic disease (previously known as anemia of inflammation) is a hypoproliferative anemia that occurs in the setting of chronic infection, inflammation, malignancy, heart failure, diabetes, and other serious health conditions. The anemia is usually mild and characterized by low serum iron, increased ferritin (remember that ferritin is an acute-phase reactant and these patients often have inflammation), decreased serum transferrin, normal (or low) serum soluble transferrin receptor level, and decreased transferrin saturation (see below for more on the soluble transferrin receptor). In addition, the reticulocyte count is typically low, the erythropoietin may be mildly elevated, and the peripheral smear may show hypochromic, microcytic RBCs or normochromic, normocytic RBCs”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

With iron levels being screwed up in both, what is the gold standard of diagnosis between iron deficient anemia and anemia if chronic disease?

A

“If differentiation between iron deficiency anemia and anemia of chronic disease is not apparent, a bone marrow biopsy can be obtained to assess iron stores.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

How does a child present with lead poisoning?

A

“Lead poisoning should be considered in a child presenting with symptoms of encephalopathy and anemia with basophilic stippling on RBCs. Basophilic stippling occurs when ribosome precipitates litter the RBCs and can be seen in alcohol abuse, thalassemias, and heavy metal poisoning”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What diseases are associated with basophilic stippling?

A

Basophilic stippling occurs when ribosome precipitates litter the RBCs and can be seen in alcohol abuse, thalassemias, and heavy metal poisoning”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

How is lead poisoning treated?

A

“Dimercaprol is a lead chelator used to treat elevated lead levels. It is administered intramuscularly, is water-insoluble, and must be given in a peanut oil vehicle. It may cause hemolysis in individuals with G6PD deficiency, so these patients should be monitored closely and not receive larger doses of dimercaprol. It is important to test siblings of an affected child, because the source of lead is often in the house. Close follow-up of affected children is essential to monitor for increasing blood lead levels after treatment, which may indicate the source of lead has not been removed. The absorption of lead can be made worse by malnutrition, iron deficiency, and poor intake of calcium. Iron deficiency frequently occurs in affected patients and may worsen anemia”

41
Q

After treatment for lead poisoning, the patient is essentially cleared of exogenous lead within their body. True or false?

A

False. “A large percentage of lead is absorbed into bone with a half-life of greater than 25 years. In periods of physiologic stress, the inert pool of lead can be mobilized and released into the bloodstream, producing signs and symptoms of lead intoxication years after the initial exposure.”

42
Q

What does the presence of anemia, target cells, splenomegally, and profoundly low MCV suggest?

A

“The clinical and laboratory presentation is consistent with a hereditary hemoglobinopathy, most likely a thalassemia. The splenomegaly, significant anemia, target cells, and the profoundly low MCV are all suggestive of thalassemia”

43
Q

What is hemoglobin electrophoresis?

A

Hemoglobin electrophoresis is a blood test that can detect different types of hemoglobin. It uses the principles of gel electrophoresis to separate out the various types of hemoglobin. The test can detect abnormal levels of HbS, the form associated with sickle-cell disease, as well as other abnormal hemoglobin-related blood disorders, such as hemoglobin C. It can also be used to determine whether there is a deficiency of any normal form of hemoglobin, as in the group of diseases known as thalassemias. Different hemoglobins have different charges, and according to those charges and the amount, hemoglobins move at different speeds in the gel whether in alkaline gel or acid gel.The hemoglobin electrophoresis is also known to be thalessemia screening, this also can be helpful for the patient who is frequently need of fresh blood transfusion.

44
Q

Beta thalassemia is generally a mild disease. T or F

A

False. “Beta thalassemia refers to the disease state in which there are mutations in both genes that code for beta globin. Without treatment, mortality from thalassemia major approaches 80% by 5 years of age. Judicious use of transfusions and concurrent chelation therapy with deferoxamine has reduced long-term complications related to the disease. Deferasirox (Exjade), an oral chelating agent, is available. Bone marrow transplant can be curative. Beta thalassemia minor (or beta trait) is much less severe and occurs when only one of the genes is defective”

45
Q

Alpha thalassemia is generally more benign than beta. T or F

A

True. “Alpha thalassemia has a more variable course. There are 4 alpha globin genes. If all 4 genes are defective, intrauterine fetal demise is the rule. When 1 gene is defective, there is a silent carrier state. When 2 genes are defective, there is a mild microcytic anemia. Here’s a memory aid: there are 4 alpha globin genes and “4” looks kind of like the “A” in “Alpha”; beta is the second letter in the Greek alphabet and beta globin has 2 genes.”

46
Q

When should one consider testing for thalassemia?

A

“Consider testing for thalassemia in a patient with microcytic anemia, normal or increased iron levels, a normal RDW (less reliable), and appropriate ethnic background (e.g., Mediterranean or African descent).”

47
Q

What is the expected course of sickle cell disease?

A

“The patient has homozygous SS sickle-cell disease. This child’s mother should be counseled regarding the importance of continuing antibiotic prophylaxis until the age of 5 years because her child is at high risk for pneumococcal sepsis. Sickle-cell disease is protective against malaria, not parvovirus (“C”). In fact, the development of a parvovirus infection can be life threatening due the development of aplastic anemia.
During infancy, children may be noted to have reticulocytosis, hemolytic anemia, and sickling by 10–12 weeks. At 5–6 months, splenomegaly may be noted, and lymphadenopathy may be prominent between 6 months and 5 years. The earliest pain crisis often involves hands and feet (dactylitis), and occurs after the HbF decreases to adult values. This usually does not occur until after age 4. The spleen involutes by 5–8 years. Puberty is delayed by an average of 2.5 years”

48
Q

What is the expected course of sickle cell trait?

A

“Sickle trait, the condition in which a patient is heterozygous for Hb S, is associated with a normal life expectancy and no symptoms other than occasional hematuria and inability to concentrate urine. Pain crises are extremely rare, and occur only in the settings of low-oxygen atmosphere (e.g., very high altitude) or extreme physical activity (e.g., running a marathon).”

49
Q

Why do patients with sickle cell disease have pain exacerbations?

A

“Two main features of sickle-cell disease are shortened RBC survival and vaso-occlusion due to poorly deformable RBC membranes. Pain episodes occur due to acute episodes of tissue hypoxemia and microinfarction. Crises can be precipitated by stress, fatigue, cold weather (not hot showers, which cause problems in multiple sclerosis patients), infection, dehydration, acidosis, and poor nutrition. The use of hydroxyurea promotes increased levels of HbF, and HbF is associated with decreased frequency and severity of pain crises”

50
Q

What is acute chest syndrome and how is it treated?

A

“Acute chest syndrome (ACS) should be suspected when a sickle-cell patient presents with fever, cough, chest pain, and pulmonary infiltrates on chest x-ray. ACS may be due to infection or pulmonary infarction. Treatment involves aggressive pain management, antibiotics for respiratory pathogens, supplemental oxygen, cautious hydration, and blood transfusion if the patient is significantly anemic. Exchange transfusion may also be required in more severe cases.”

51
Q

What is the prognosis for patients with sickle cell disease?

A

“The average life expectancy in patients with Hb SS is 42 years for men and 48 years for women. Maternal mortality occurs in about 1% of pregnancies. All of the rest are true including cerebrovascular events causing seizures and possible cognitive difficulty early in life. 80% of patients develop cholelithiasis by age 35. ACS and pain crises are the most common cause of admission. Of particular note, renal failure may be the cause of death in up to 10% of cases. Avascular necrosis and osteomyelitis (classically as a result of Salmonella infection), chronic skin ulcers, and priapism are also common.”

52
Q

What is the most likely diagnosis in a patient with Celiac disease, macrocytic anemia and a normal serum B12?

A

“folate deficiency, given a normal B12, macrocytic anemia, and risk factors for folate deficiency—old age, poor diet, avoidance of gluten (flour is normally fortified with folate), use of phenytoin, and possible malabsorption due to GI disease (celiac disease in this case, but also any other infiltrating or inflammatory process of the bowel)”

53
Q

How common is dietary deficiency in folate?

A

“Dietary deficiency is uncommon in the United States due to supplementation of grain products with folate. Foods naturally high in folate include melons, bananas, leaf vegetables, asparagus, and broccoli. The recommended intake is 400 μg/day, and the body stores approximately a 4-month supply. If he has had recent adequate folate intake, the serum folate level may be normal, but the RBC folate will still be low, reflecting the deficiency (think of it as the HbA1C of folate)”

54
Q

What serum markers help differentiate folate from B12 deficiency?

A

“To differentiate folate from B-12 deficiency, check serum homocysteine and methylmalonate levels. Both will be elevated with B-12 deficiency, while only homocysteine will be elevated in folate deficiency. Remember, you must exclude B12 deficiency before replacing folate, because folate replacement can reverse the anemia but will permit progression of neurologic effects of B12 deficiency”

55
Q

What is pernicious anemia and how does it manifest?

A

pernicious anemia is caused by B12 deficiency. Pernicious anemia is caused by immune destruction of parietal cells in the stomach, resulting in decreased absorption of B12. It typically develops in people over the age of 40 and is more common in people of northern European descent or in African Americans, as well as people with type A blood. Laboratory findings include antiparietal cell antibodies in 90% of affected patients (5% of normal individuals) and antibodies to intrinsic factor in 70% of patients. Individuals commonly have other autoimmune diseases such as thyroid disease, diabetes, and vitiligo. Individuals may complain of paresthesias, GI symptoms, sore tongue, or weight loss. The lemon-yellow appearance of the skin is due to anemia and mild jaundice”

56
Q

What cause B12 deficiency?

A

Autoimmune disorder destroying the parietal cells of the stomach. “Other causes of cobalamin (B12) deficiency include gastrectomy, Zollinger-Ellison syndrome (inability to alkalinize the small intestine), blind loop syndrome, bacterial overgrowth from previous surgery, and ingestion of undercooked fish infested with the tapeworm Diphyllobothrium latum (found in Canada, Alaska, and the Baltics—hence, the history of working as a park ranger). Although a strict vegetarian diet can cause B12 deficiency, there are sufficient stores to last 3–5 years (in other words, more than 1 month).”

57
Q

How does a patient with Wilson’s disease present and what is the treatment?

A

“This patient likely has Wilson disease (an autosomal-recessive defect in cellular copper export), which presents with decreased levels of ceruloplasmin, increased liver enzymes, and signs of hemolysis (from the direct toxic effect of copper on the cell). Symptoms typically present in the teens and early twenties. Presenting symptoms may include Kayser–Fleisher rings (golden-brown pigmentation of the cornea), hemolytic anemia, or neurologic symptoms, often mimicking psychiatric illness. Treatment of the disease includes lifelong therapy with penicillamine or trientine (chelating agents), and should be considered even for asymptomatic individuals known to have the disease.”

58
Q

How does a patient with multiple myeloma present and what is the workup?

A

“A spontaneous vertebral fracture in a 50-year-old male is definitely not normal. Multiple myeloma should be considered in patients with this presentation.
Multiple myeloma is a clonal disorder of plasma cells. Risk factors include African American race, male sex, and advancing age (median age of 60–65 at presentation). Workup for the diagnosis of multiple myeloma requires a serum and urine protein electrophoresis with immunofixation. This will help to identify a monoclonal protein. Quantitative immunoglobulins will help to assess whether this patient has an elevation of immunoglobulins in the range required for the diagnosis of multiple myeloma. A skeletal survey and bone marrow biopsy complete the diagnostic workup. A bone scan is not useful because the lytic lesions characteristic of multiple myeloma do not take up radioisotope.”

59
Q

An incidental monoclonal IgG spike/elevation is found. The patient is asymptomatic. What is the disease and how do you monitor it?

A

““Monitor blood, including serum immunoglobulins, every 3–6 months and, if stable after 1 year, annually thereafter.” The disease is monoclonal gammopathy of undetermined significance, or MGUS, which is found in up to 3% of asymptomatic older individuals. A bone marrow biopsy indicating 10% plasma cells is required to make the diagnosis of multiple myeloma; this patient only has 6%. Additionally, this patient has a normal CBC and is asymptomatic (no fatigue, bone pain suggestive of lesions, etc.). Thus, this patient has MGUS. Patients with MGUS typically do well, with only 1% per year progressing to multiple myeloma.
While patients should be reassured of the typically benign nature of this condition, up to 30% will have complications (multiple myeloma, amyloidosis, other myeloproliferative disorders)”

60
Q

How do patients with myelodysplastic syndrome present and what is the course of the disease?

A

They’re older adults with fatigue who have recently suffered recurrent infections. “Patients with MDS can be pancytopenic. MDS includes a number of clonal stem cell disorders characterized by dysplasia and ineffective hematopoiesis of one or more cell lines. The disease is typically one of older adults, with a median age of 65–70 years at onset; however, a better prognosis is associated with age <60 and female gender. There is an increased risk of MDS in smokers, those exposed to benzene or alkylating agents, and with some hereditary disorders. Prognosis depends on the number of blasts, the number of lineages affected, and cytogenetic abnormalities. Median survival ranges from 10 to 66 months, and progression to acute leukemia ranges from 6% to 33% of patients, depending on the subtype of MDS.”

61
Q

What is the treatment of myelodysplastic syndrome?

A

“Depending on the age and overall performance status of the individual MDS patient, treatment can range from supportive care with blood or platelet transfusions, to treatment with granulocyte colony stimulating factor (GCSF), to chemotherapeutics such as azacytidine, or even to bone marrow transplantation”

62
Q

What defines neutropenia in the pediatric population?

A

“In the pediatric population, neutropenia is typically described as an ANC of <1000/mm3 (e.g., no increased risk of infection). At birth, neutrophils make up the majority of the WBC differential, and this decreases to 20–30% after the first few days of life. At 5 years of age, neutrophils comprise approximately 50% of the differential, and this reaches 70% by puberty”

63
Q

What is the ‘classic’ history of hemochromatosis?

A

Symptoms start during or after the fifth decade of life, are initially mild, and progress slowly. “Bronze diabetes” (bronze or tan skin color due to iron deposition accompanied by hyperglycemia) is sometimes noted. Most organs can eventually be involved, but most commonly symptoms are due to liver, cardiac, joint, and testicular involvement”

64
Q

What is the expected iron levels in a patient with hereditary hemochromatosis?

A

“All of these iron studies (iron, ferritin & transferrin levels) are elevated in patients with hereditary hemochromatosis. A normal person maintains approximately 3–4 g of iron in the body. Normal individuals absorb about 1 mg/day of iron (10% of what is ingested), which is precisely balanced with loss through sweat, sloughing of cells, and GI losses. In hereditary hemochromatosis, 2–4 mg of iron is absorbed daily, resulting in the accumulation of iron.”

65
Q

Name 2 epidemiological facts about hereditary hemochromatosis and describe its treatment.

A

“Hereditary hemochromatosis is an autosomal-recessive disorder. Approximately 10% of Caucasians are heterozygous, and 5/1000 are homozygous for the gene mutation. Patients are at increased risk for infections due to Listeria, Vibrio vulnificus (sorry, no sushi!), and Yersinia enterocolitica. Affected females may present later in life due to increased iron losses from menstruation, pregnancy, and lactation.
Treatment includes phlebotomy or chelation therapy if phlebotomy is contraindicated. Patients should be monitored closely for development of hepatoma, since therapy does not reduce the risk of hepatocellular carcinoma once cirrhosis is present. Family members should be screened for the disease so they can be started on therapy early, in order to prevent the development of cirrhosis”

66
Q

What is methemoglobinemia?

A

“Certain drugs such as nitroprusside, sulfonamides, some local anesthetics, and acetaminophen have been found to cause methemoglobinemia. Methemoglobinemia results when iron in Hb is oxidized from the ferrous to the ferric state and the Hb becomes incapable of binding and transporting oxygen. The blood gas oxygen may look normal because the RBCs cannot release oxygen (and thus remain oxygenated). However, the pulseoximeter will show a low O2 saturation. So, there is often a gap between what you see on the blood gas and what the pulse- oximeter suggests.”

67
Q

How does a patient with methemoglobinemia present?

A

“In a normal patient, less than 1% of Hb is found in the methemoglobin form. Depending on the percentage of methemoglobin, presentations will vary. At 10–20%, patients present with cyanosis refractory to oxygen. The arterial blood gas may show a normal PaO2with low oxygen saturations. When methemoglobin levels are >30%, patients present with headache, dizziness, dyspnea, and tachypnea. At >50%, patients develop stupor and obtundation, and >70% may be lethal.”

68
Q

What is the treatment of methemoglobinemia?

A

“Treatment of methemoglobinemia is methylene blue. However, patients with G6PD deficiency should not be given methylene blue, and hyperbaric oxygen therapy should be considered instead. Remember, when patients have been exposed to cyanide, you want to cause methemoglobinemia. The exact mechanism by which this protects against cyanide is unknown, since patients begin to improve prior to the presence of methemoglobinemia.”

69
Q

What is G6PD deficiency and how does it present?

A

“G6PD deficiency is the most common inherited RBC enzyme defect, affecting 10% of the black male population. It occurs more commonly in African and Mediterranean populations.”

It presents with “hemolytic anemia, as evidenced by the elevated LDH, bite cells, elevated bilirubin, low haptoglobin, and the acute onset of symptoms. Heinz bodies are inclusions in red cells seen on peripheral smear within the first few days of an oxidative stress in patients with G6PD deficiency. Bite cells are formed as the red cells pass through the spleen and the Heinz bodies are removed.

70
Q

Name 3 substances that can cause a hemolytic crisis in people with G6PD deficiency.

A

“Sulfa antibiotics, Fava beans, Nitrofurantoin & Some antimalarial drugs”

“Multiple other drugs can be involved as well including vitamin C, salicylates, isoniazid, and phenytoin.”

71
Q

What is the treatment for hemolytic anemia in patients with G6PD disease?

A

“The hemolytic anemia of G6PD deficiency is self-limited and will resolve. This is because in most cases of G6PD deficiency, only about 25% of the RBCs (the older cells) are susceptible to oxidative stress. Severe episodes should be treated in the hospital setting, but most episodes can be managed as an outpatient. Patients should be educated on the drugs and stressors that may precipitate an episode of hemolytic anemia. Splenectomy may limit hemolysis in patients with more severe disease.”

72
Q

What is CLL?

A

B-cell chronic lymphocytic leukemia (B-CLL), also known as chronic lymphoid leukemia (CLL), is the most common type of leukemia in adults.[1] Leukemias are cancers of the white blood cells (leukocytes). CLL affects B cell lymphocytes. B cells originate in the bone marrow, develop in the lymph nodes, and normally fight infection by producing antibodies. In CLL, B cells grow out of control and accumulate in the bone marrow and blood, where they crowd out healthy blood cells. CLL is a stage of small lymphocytic lymphoma (SLL), a type of B-cell lymphoma, which presents primarily in the lymph nodes.[2] CLL and SLL are considered the same underlying disease, just with different appearances.

73
Q

Who is affected by CLL and how is the diagnosis made?

A

CLL is a disease of adults, but, in rare cases, it can occur in teenagers and occasionally in children (inherited). Most (>75%) people newly diagnosed with CLL are over the age of 50, and the majority are men.

Most people are diagnosed without symptoms as the result of a routine blood test that returns a high white blood cell count, but, as it advances, CLL results in swollen lymph nodes, spleen, and liver, and eventually anemia and infections.

74
Q

What is the treatment of CLL?

A

While generally considered incurable, CLL progresses slowly in most cases. Many people with CLL lead normal and active lives for many years—in some cases for decades. Because of its slow onset, early-stage CLL is, in general, not treated since it is believed that early CLL intervention does not improve survival time or quality of life. Instead, the condition is monitored over time to detect any change in the disease pattern. Late CLL is treated with chemotherapy and monoclonal antibodies.

75
Q

What are patients with CLL at risk for?

A

“Patients with CLL are at risk for developing autoimmune diseases, including hemolytic anemia, autoimmune thrombocytopenia, pure red cell aplasia, and autoimmune neutropenia.”

76
Q

How should patient with CLL be monitored?

A

“They should be monitored every 6–12 months or sooner if they develop symptoms, such as infections, fatigue, bulky lymphadenopathy, or bleeding.”

77
Q

What is chronic myelogenous leukemia?

A

CML is a cancer of the white blood cells. It is a form of leukemia characterized by the increased and unregulated growth of predominantly myeloid cells in the bone marrow and the accumulation of these cells in the blood. CML is a clonal bone marrow stem cell disorder in which a proliferation of mature granulocytes (neutrophils, eosinophils and basophils) and their precursors is found. It is a type of myeloproliferative disease associated with a characteristic chromosomal translocation called the Philadelphia chromosome.

78
Q

How is CML treated?

A

CML is now largely treated with targeted drugs called tyrosine kinase inhibitors (TKIs) which have led to dramatically improved long term survival rates since the introduction of the first such agent in 2001. These drugs have revolutionized treatment of this disease and allow most patients to have a good quality of life when compared to the former chemotherapy drugs.

79
Q

What is the treatment for a patient with probable leukemia and fever?

A

“Patients with acute leukemia and fever should be cultured, and antibiotics should be started as soon as possible since a fever is often the result of a concurrent infection. These patients should be kept well hydrated and given allopurinol to prevent tumor lysis syndrome, as this can occur even without chemotherapy if the tumor burden is high enough. Treatment of acute leukemias requires intensive chemotherapy and should be started as soon as possible, so prompt evaluation by a hematologist/oncologist is imperative.”

80
Q

What does an elevated haptoglobin suggest?

A

“An elevated haptoglobin would suggest the absence of active hemolysis.”

81
Q

What is the classic pentad of TTP?

A

1) microangiopathic hemolytic anemia (suggested by schistocytes on peripheral smear)
2) thrombocytopenia,
3) fever
4) renal insufficiency
5) mental status changes

82
Q

Name two drugs that can cause TTP.

A

Quinine, Clopidogrel and ticlopidine

83
Q

What are schistocytes and when do they occur?

A

“Schistocytes are the result of intravascular trauma to RBCs. Any microangiopathic hemolytic anemia can result in schistocytes as can other intravascular trauma such as that secondary to artificial heart valves, HELLP syndrome, malignant hypertension, some malignancies, transjugular intrahepatic portosystemic shunts (TIPS), eclampsia, etc.”

84
Q

What is the significance of the normal PT/INR ratio in a patient with TTP?

A

“This is important because TTP can be confused with DIC, in which the PT/INR should be elevated and fibrinogen should be low”

85
Q

When patients are poorly responsive to therapy for TTP what other things should be considered?

A

“When patients are poorly responsive to therapy, an alternative diagnosis should be sought. In pregnant patients, preeclampsia or HELLP syndrome can mimic TTP. Autoimmune disease (e.g., systemic lupus erythematosus and scleroderma), malignant hypertension, and disseminated malignancy may also mimic TTP. Infections that can be confused with TTP include Rocky Mountain spotted fever, disseminated aspergillosis, as well as any other disease that can cause mental status changes and a low platelet count such as as Ehrlichiosis, Anaplasmosis, West Nile virus, etc.”

86
Q

What is DIC?

A

disseminated intravascular coagulation is a pathological process characterized by the widespread activation of the clotting cascade that results in the formation of blood clots in the small blood vessels throughout the body. This leads to compromise of tissue blood flow and can ultimately lead to multiple organ damage. In addition, as the coagulation process consumes clotting factors and platelets, normal clotting is disrupted and severe bleeding can occur from various sites. DIC does not occur by itself but only as a complicating factor from another underlying condition, usually in those with a critical illness

87
Q

What is the treatment for DIC?

A

“Treatment is directed at correcting the underlying cause of DIC whenever possible. Patients may benefit from platelet transfusion to maintain a platelet count above 20,000/mm3, but transfusion at higher levels can worsen platelet aggregation. Transfusion of FFP will replace consumed factors. Patients with low fibrinogen levels will benefit from transfusion of cryoprecipitate. The use of heparin is generally limited to those with low grade, chronic DIC with thrombotic complications. It may also be considered acutely if there are prominent thrombotic complications”

88
Q

What is the treatment for Hodgkin’s disease?

A

“Chemotherapy regimens for Hodgkin disease have resulted in response rates of more than 90%, with fewer long-term complications than prior regimens”

89
Q

What is Hodgkin’s disease?

A

“Hodgkin’s is an uncommon disease, with about 8000 cases occurring each year in the United States. It is a disease of young people, occurring typically in patients in their 20s. Patients often present with lymphadenopathy. Symptoms, known as “B symptoms,” include weight loss, fever, and drenching night sweats. Other symptoms may include pruritus, diffuse pain after consuming alcoholic beverages (sigh….), and symptoms related to the development of a mediastinal mass. After a diagnostic lymph node biopsy, further staging includes CT scans, bone marrow biopsy, and routine labs.”

90
Q

What is non-Hodgkin’s lymphoma?

A

NHL consists of 16 different conditions that have little in common with each other. They are grouped by their aggressiveness. Less aggressive non-Hodgkin lymphomas are compatible with a long survival while more aggressive non-Hodgkin lymphomas can be rapidly fatal without treatment. Without further narrowing, the label is of limited usefulness for patients or doctors.

91
Q

What are some of the causes of non-Hodgkin’s lymphoma?

A

Infectious agents:
Epstein-Barr virus – associated with Burkitt’s lymphoma, Hodgkin’s lymphoma, follicular dendritic cell sarcoma, extranodal NK-T-cell lymphoma
Human T-cell leukemia virus – associated with adult T-cell lymphoma
Helicobacter pylori – associated with gastric lymphoma
HHV-8 – associated with primary effusion lymphoma, multicentric Castleman disease
Hepatitis C virus – associated with splenic marginal zone lymphoma, lymphoplasmacytic lymphoma and diffuse large B-cell lymphoma[5]
HIV infection[6]
Some chemicals, like polychlorinated biphenyls (PCBs), diphenylhydantoin, dioxin, and phenoxy herbicides.
Medical treatments, like radiation therapy and chemotherapy
Genetic diseases, like Klinefelter’s syndrome, Chédiak-Higashi syndrome, ataxia telangiectasia syndrome
Autoimmune diseases, like Sjögren’s syndrome, celiac sprue, rheumatoid arthritis, and systemic lupus erythematosus.

92
Q

What is the treatment for DVT?

A

“You should start her on heparin (or low-molecular-weight heparin) and warfarin with a goal INR of 2–3. Heparin should be used for at least 5 days and overlapped with therapeutic doses of warfarin that have reached the target INR for at least 48 hours. She should be anticoagulated for at least 3 months. Encourage her to stop smoking and to find an alternative form of birth control.”

93
Q

What are the causes of inherited coagulation disorders?

A

“There are essentially seven types of thrombophilia for which you might initially test: factor V Leiden mutation, antithrombin III deficiency, prothrombin gene mutation, protein C deficiency, protein S deficiency, antiphospholipid antibody syndrome, and hyperhomocysteinemia”

94
Q

Which coagulation tests are affected by giving warfarin?

A

“warfarin can reduce protein C and S levels (giving false-positive test results) and increase antithrombin levels (giving a false-negative result).”

95
Q

What is the most commonly inherited coagulation disorder?

A

“Factor V Leiden mutation is the most common cause of inherited thrombophilia, being found in 3–6% of nonblack blood donors. Antithrombin deficiency (previously known as antithrombin III) is less common, occurring in 1/1000–1/5000 individuals. The homozygous condition is fatal in utero. Heterozygotes have a 30% chance of developing a thromboembolic event by age 30. Protein C deficiency occurs in 1/200–1/300 people; however, fewer than 1/1000 heterozygotes develop venous thromboses. Protein S deficiency is estimated to occur in 0.03–0.13% of persons and has a clinical presentation similar to protein C deficiency.” “antiphospholipid antibody syndrome is an acquired disorder that is associated with arterial as well as venous thromboembolic events. Finally, hyperhomocysteinemia is associated with the development of venous thrombosis and atherosclerotic heart disease.”

96
Q

Tell me three things about pregnant chicks developing DVTs.

A

“DVT, and the broader category of venous thromboembolism (VTE), occurs two to four times more often in pregnant women compared to nonpregnant controls. Increased risk is found with cesarean delivery versus vaginal delivery. The majority of DVTs occur in the left lower extremity of pregnant women, likely due to the compression of the left iliac vein by the right iliac artery as they cross. The increased incidence of VTE is multifactorial, including increased levels of fibrinogen, factor VIII, and vWF; increased venous stasis; increased venous distension secondary to increased estrogen; and anatomic distortion related to the gravid uterus”

97
Q

DVT is more common in the third trimester of pregnancy. True or false?

A

“VTE occurs equally during all three trimesters, but increased lower extremity swelling is frequently seen in normal patients during the third trimester, making the diagnosis less obvious.”

98
Q

What are the treatment options for DVT in pregnancy?

A

“Treatment of VTE with anticoagulation is more difficult in a pregnant woman. Warfarin crosses the placenta and has teratogenic effects in addition to increased risk of fetal bleeding. Heparin and danaparoid do not cross the placenta, but are associated with a 2% risk of maternal bleeding. Heparin also carries the risks of heparin-induced thrombocytopenia with thrombosis, osteoporosis, and bleeding at the uteroplacental junction. Dosing of unfractionated heparin is difficult during pregnancy, and low-molecular-weight heparin is probably the best choice for anticoagulation. Heparin and warfarin are safe for lactating mothers.”

99
Q

The patient is adequately anticoagulated with warfarin and evolves a PE what is the next appropriate step in management?

A

“Patients who have a new VTE while on appropriate anticoagulant therapy should be evaluated for antiphospholipid antibody syndrome. This patient has a prolonged PTT, which is also suspicious for an antiphospholipid antibody. She was an outpatient prior to having her blood drawn and was not taking heparin, so contamination with heparin is unlikely”

100
Q

What is antiphospholipid syndrome?

A

An autoimmune, hypercoagulable state caused by antiphospholipid antibodies. Antiphospholipid syndrome can be primary or secondary. Primary antiphospholipid syndrome occurs in the absence of any other related disease. Secondary antiphospholipid syndrome occurs with other autoimmune diseases, such as systemic lupus erythematosus (SLE). In rare cases, APS leads to rapid organ failure due to generalised thrombosis; this is termed “catastrophic antiphospholipid syndrome” (CAPS) and is associated with a high risk of death.
Antiphospholipid syndrome often requires treatment with anticoagulant medication such as heparin to reduce the risk of further episodes of thrombosis and improve the prognosis of pregnancy. Warfarin/Coumadin is not used during pregnancy because it can cross the placenta, unlike heparin, and is teratogenic.

101
Q

In a patient who has had a VTE (venous thromboembolism) within three months of a surgery, what is the appropriate anticoagulation therapy?

A

“Patients who have a VTE within 1 month of surgery have a 50% risk of a second VTE if not treated aggressively with anticoagulation. These recurrent events carry a mortality rate of approximately 6%. Such patients should be placed on heparin before and after surgery” “Patients with a VTE within 1–3 months before a scheduled surgery should be considered for postoperative heparin therapy, while a VTE >3 months before the scheduled surgery should not pose significant additional risk, and established prophylaxis guidelines should be followed.”